Neurology

Dizziness and vertigo are among the most common complaints primary care physicians see in their offices or hear about during their virtual visits. What do you know about dizziness and vertigo?

Study suggests minimal risk of relapse when Pfizer-BioNTech mRNA COVID-19 vaccine is given to patients with a history of GBS.

A pharmacist at North York General Hospital helps older patients with Parkinson’s disease navigate symptoms and adverse events, one call at a time.

Insomnia is a common complaint many physicians hear, and its incidence has only increased since the global pandemic. Test your knowledge on insomnia and its treatment.

The U.S. Food and Drug Administration recently approved aducanumab, the first treatment that aims to slow the progression of Alzheimer’s disease. But approval of the drug has provoked mixed reactions from the scientific community.

U.S. government health officials on Monday approved the first new drug for Alzheimer's disease in nearly 20 years, disregarding warnings.

Third oral sphingosine 1-phosphate receptor modulator to be marketed for MS in Canada.